表紙
市場調查報告書

管瓶,盒,注射器用合成橡膠栓的全球市場:2019-2030年

Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

出版商 ROOTS ANALYSIS 商品編碼 836182
出版日期 內容資訊 英文 385 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
管瓶,盒,注射器用合成橡膠栓的全球市場:2019-2030年 Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures
出版日期: 2019年05月31日內容資訊: 英文 385 Pages
簡介

本報告提供非口服醫藥品容器用的合成橡膠栓的市場調查,彙整市場定義和概要,合成橡膠木材的特徵,醫藥品容器的各種栓·保護蓋種類與重要性,產品及製造商的清單,近幾年的認證核可藥的包裝趨勢,容器類型·栓類型·殺菌區分·不同地區的需求及市場規模的變化與預測,醫藥品包裝的機器人工學所扮演的角色相關分析,醫藥品包裝的新興趨勢分析等資料。

第1章 序論

第2章 摘要整理

第3章 簡介

  • 本章概要
  • 醫藥品包裝
    • 類型
    • 革新
    • 傳統的醫藥品無菌填充
    • 傳統初級包裝的局限性
  • 容器封閉系統在藥品包裝中的作用
  • 醫藥品用栓的各種類型
    • 注射器用
    • 管瓶用
    • 濾芯用
  • 材料選擇標準
  • 合成橡膠包裝材料費
    • 特徵
    • 一般的類型
    • 法律規章指南
    • 製造流程
    • 品質評估
    • 優點及缺點
  • 總論

第4章 市場環境

  • 本章概要
  • 非口服容器用合成橡膠栓:產品清單
  • 非口服容器用合成橡膠栓:製造商清單
  • 主要舉措
  • 總論

第5章 企業簡介

  • 本章概要
  • 主要企業:北美
    • Aptar Pharma
    • DWK Life Sciences
    • West Pharmaceutical Services
  • 主要企業:歐洲
    • Datwyler Sealing Solutions
    • Lonstroff
    • Ompi
  • 主要企業:亞太地區
    • 大協精工
    • Hebei First Rubber Medical Technology
    • Jiangsu Hualan New Pharmaceutical Material

第6章 近幾年已通過核准藥的包裝趨勢

  • 本章概要
  • 認證核可藥清單

第7章 近幾年的發展

  • 本章概要
  • 醫藥品包裝產業:聯盟活動
  • 近幾年的擴張趨勢
  • 近幾年的會議
  • 總論

第8章 需求分析

  • 本章概要
  • 調查範圍·調查手法
  • 全球合成橡膠栓需求的轉變·預測
    • 各容器類型
      • 管瓶
      • 注射器
      • 濾芯
    • 各栓類型
      • 密封
      • 柱塞
      • 針頭保護蓋
    • 各殺菌種類
      • 已殺菌栓
      • 非殺菌栓
    • 各地區
  • 總論

第9章 市場規模的轉變·預測

  • 本章概要
  • 市場預測
    • 各容器類型
    • 各栓類型
    • 各殺菌種類
    • 各地區
  • 總論

第10章 案例研究:醫藥品包裝的機器人工學

  • 本章概要
  • 醫藥品產業上機器人工學所扮演的角色
  • 提供醫藥品產業機器人的企業
  • 醫藥品包裝機器人用整合設備的提供企業

第11章 醫藥品包裝的新興趨勢

  • 本章概要
  • 轉變到使用先進的藥物輸送設備之自我治療
  • 注於開發改進的包裝組件和不斷努力以優化製造成本
  • 組合式設備的可用性
  • 專注於填充/完成操作自動化的計劃
  • 建立業務關係,專注於為各種藥品設計兼容的包裝材料
  • 新興地區的活性化
  • 智慧包裝解決方案的引進擴大
  • 總論

第12章 重要考察

第13章 附錄:圖表資料

第14章 附錄:企業·組織清單

目錄
Product Code: RA100136

Example Insights:

The elastomeric container closures market is fragmented, featuring the presence of a large number of established players; a relatively larger proportion of small-sized players are based in developing geographies.

Overview:

Pharmaceutical packaging plays a crucial role in ensuring the sterility and quality of a drug product, while also providing information related to its identity and, in certain cases, dosing instructions. Primary packaging material, owing to the fact that it is in immediate contact with the drug / therapy formulation, is considered to be extremely important when it comes to preserving the stability, efficacy and safety of the packaged drug product. Further, given the growing complexity of modern pharmacological interventions, especially biologics, it has become imperative for drug / therapy packaging considerations to be re-evaluated, taking into consideration the evident shift from large batches of one remedy for everyone to smaller batches of more personalized therapeutic solutions. In addition to optimizing drug-packaging compatibility, stakeholders in the pharmaceutical packaging industry have also adopted a number of other flexible solutions to reduce the overall cost and expedite time to market.

“One of the main reasons for choosing elastomeric materials for manufacturing closures is their anti-leaching property and limited interaction potential of the material with the formulation present in vial / syringe. Further, using ready-to-use products saves a lot of time and effort in the overall production processes.” -- Project Manager, Business Development, a US based mid-sized company.

The use of elastomeric materials, along with various types of coatings (such as FluoroTec® and Teflon®), has emerged as a promising alternative to conventional, non-coated closures used for primary packaging containers, which were prone to leaching and shedding of particulate contaminants. The advantages of using elastomeric materials in manufacturing container closures are many, including low leaching potential, minimal chemical interaction with the pharmacological formulation, and the fact that they can be used to make waterproof and airtight closures. Moreover, such closures can also be manufactured in the ready-to-use (RTU) format, which saves a significant amount of time by eliminating the need for multiple steps in the overall fill / finish process. Owing to the aforementioned benefits, the industry has witnessed an evident growth in preference for elastomeric container closures.

Scope of the Report:

The ‘Elastomeric Closures Market: Focus on Parenteral Containers, 2019-2030’ report features a comprehensive study of the current scenario and future potential of the elastomeric, primary packaging closure market. It features an in-depth analysis, highlighting the various types of elastomeric closures including stoppers, needle shields and plungers, available in the market for various types of primary packaging containers, such as cartridges, syringes and vials. In addition to other elements, the study includes:

  • A detailed assessment of the current market landscape of companies manufacturing elastomeric container closures, featuring information on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if the closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product.
  • A comprehensive analysis on the packaging trends of over 230 drug products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014), featuring an assessment of the packaging requirements of various container-closure systems based on parameters, such as year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure, and leading drug developers (in terms of number of drugs packaged using elastomeric closures).
  • An analysis of various developments / recent trends related to elastomeric packaging materials, offering insights on (A) partnerships and collaborations established within the industry, and (B) recent global conferences related to pharmaceutical packaging industry.
  • Elaborate profiles of key players in this domain (shortlisted on the basis of size of product portfolio), featuring a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of the executive team), financial information (if available), detailed description of proprietary elastomeric closures, recent developments, and an informed future outlook.
  • A case study on the role of robotics in pharmaceutical manufacturing and fill / finish operations, highlighting the advantages of using automation / automated technologies in such processes. It includes profiles of industry players offering such equipment for the aseptic processing of pharmaceutical products.
  • An elaborate discussion on emerging trends (such as focus on personalized therapies, shift towards more flexible packaging, upgrading packaging components to enhance drug product safety, and growing adoption of smart packaging solutions) that are likely to have an impact on the future adoption of elastomeric container-closure components in the pharmaceutical packaging industry. It also features a Harvey ball analysis, highlighting the relative effect of each trend on the overall pharmaceutical packaging industry.
  • An in-depth analysis to estimate the current and future demand for elastomeric closures across key primary packaging containers, including vials, syringes and cartridges, in different regions for the period 2019-2030. Input parameters considered for this analysis include current supply of different primary packaging components and their respective closures and the estimated the proportion of elastomeric closures that are likely to be supplied, which is indicative of the demand.
  • One of the key objectives of the report was to estimate the existing market size and identify potential growth opportunities for elastomeric closures over the coming decade. Based on several parameters, such as target consumer segments, region specific adoption rates and expected prices of such products, we have provided an informed estimate on the likely evolution of the market over the period 2019-2030. The report provides sales forecasts for the overall elastomeric closure market, wherein both the current and upcoming opportunity is segmented across (A) type of packaging container(s) (vials, syringes and cartridges), (B) type of closure(s) used (seal, stopper, cap, plunger, barrel, and needle shield), (C) sterilization status (pre-sterilized and unsterilized), and (D) key geographies (North America, Europe, Asia-Pacific, and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry's growth.

The opinions and insights presented in this study were also influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names):

  • Julien Maréchal (Business Development and Technology Director, Aseptic Technologies)
  • Malcolm Gilmore (Facilitator, BioPhorum Operations Group)
  • Marco Pederiva (Marketing and Sales Director, Lonstroff)
  • Konstantin Kazarian (Project Manager of Business Development, PYRAMID Laboratories)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Chapter Outlines:

Chapter 2 provides an executive summary of the insights captured during our research. It offers a high-level view on the current state of the market of elastomeric closures and its likely evolution in the short-mid term and long term.

Chapter 3 provides an overview of conventional pharmaceutical packaging and the limitations associated with the currently used container-closure systems. The chapter also lays emphasis on innovation in the pharmaceutical packaging industry and the consequent growth of flexible fill / finish solutions. It features an elaborate discussion on the different considerations for choosing a suitable material for fabricating container-closure systems. Further, the chapter includes a detailed discussion on elastomeric materials, highlighting their properties, and applications across various industries. In addition, it provides an overview of regulatory guidelines associated with elastomeric container-closure systems. It elaborates on the various tests that are necessary to assess and control the quality of elastomeric closures. It concludes with a brief discussion on the advantages and limitations of elastomeric closures, highlighting the growing importance of coated elastomeric materials.

Chapter 4 provides a comprehensive review of the current market landscape of nearly 100 elastomeric closures. It includes a detailed analysis of the aforementioned products based on the type of closure (cap, needle shield, plunger, seal, stopper, and tip cap), type of respective primary container(s) (vial, syringe, and cartridge), elastomeric material(s) used for fabricating the aforementioned closures (such as bromobutyl, chlorobutyl, and others), drug type(s) that are compatible with elastomeric closures, sterilization status of closures (pre-sterilized and unsterilized), affiliated sterilization technique (if closure(s) is available in the pre-sterilized format), scale of production (small scale, and large scale), type of customization (if available), affiliated dimensions, along with compliance certifications of the product. It also provides details of the manufacturer companies, such as year of establishment, company size, and location of headquarters.

Chapter 5 features detailed profiles of key players (shortlisted on the basis of size of product portfolio) that are involved in fabricating and supplying elastomeric closures. Each company profile features a brief overview of the company (including information on company headquarters, year of establishment, number of employees, and key members of executive team), financial information (if available), detailed descriptions of proprietary elastomeric closures, recent developments and an informed future outlook.

Chapter 6 features packaging trends of over 230 drugs products (including both biologics and small molecule drugs) that were approved over the last five years (beginning 2014). The chapter comprises of in-depth analyses, highlighting the packaging requirements of various container-closure systems based on several parameters, including year of approval of drug, type of molecule, dosage form, route of administration, holding temperature, type of packaging material(s) used for manufacturing primary container and affiliated closure. Furthermore, we have highlighted the leading players in this domain, based on the number of approved drugs packaged using elastomeric closures in the given time period.

Chapter 7 features a detailed assessment of various developments / recent trends related to elastomeric packaging materials. The analysis presented in this chapter offers insights on (A) recent partnerships and collaborations that have been established in the last decade, featuring a comprehensive set of analyses, based on various parameters, such as the year of establishment and headquarters of each company, type of partnership, purpose of collaboration, and type of product, and (B) recent global conferences related to pharmaceutical packaging industry, featuring a set of analyses based on various parameters, such as year, location, and agenda of the conference.

Chapter 8 provides an overview of the current and future demand for elastomeric closures for key primary packaging containers, including vials, syringes and cartridges, in the contemporary market. In order to estimate the aforementioned demand, we considered the current supply of different primary packaging components and their respective closures and estimated the proportion of elastomeric closures that are likely to be supplied to the pharmaceutical industry. We also estimated the likely adoption of such products across geographical regions, over the period 2019-2030.

Chapter 9 presents a comprehensive market forecast analysis, highlighting the future potential of the market till 2030, based on multiple parameters, such as current demand for respective packaging components, likely adoption rates and the estimated price of components. It includes future sales projections of various closures of key packaging containers. We have segregated the current and upcoming opportunity on the basis of (A) type of packaging container(s) (vials, syringes and cartridges), (B) type of packaging closure(s) (seal, stopper, cap, plunger, barrel, and needle shield), (C) sterilization status (pre-sterilized and unsterilized), and (D) key geographies (North America, Europe and, Asia-Pacific and Rest of the World). It is worth mentioning that we adopted a bottom-up approach for this analysis, backing our claims with relevant datapoints and credible inputs from primary research.

Chapter 10 presents an elaborate case study on the role of robots in the pharmaceutical manufacturing and fill / finish process. It features a list of the various types of pharmaceutical robots, along with details on their respective manufacturer(s) and applications. Further, the chapter includes profiles of players that offer robotic machinery for pharmaceutical manufacturing and fill / finish operations, along with information on the key specifications of such products.

Chapter 11 discusses key trends in the overall pharmaceutical manufacturing industry. Specifically, it elaborates on the emerging focus on personalized therapies, shift towards more flexible packaging, development of modular facilities, upgrading packaging components to enhance drug product safety, increase in partnership activity, and growing adoption of smart packaging solutions, among others.

Chapter 12 is a collection of interview transcripts of discussions held with key stakeholders in this market. In this chapter, we have presented the details of interviews held with (in alphabetical order of company names) Julien Maréchal (Business Development and Technology Director, Aseptic Technologies), Malcolm Gilmore (Facilitator, BioPhorum Operations Group), Marco Pederiva (Marketing and Sales Director, Lonstroff), and Konstantin Kazarian (Project manager of Business Development Project Manager, PYRAMID Laboratories).

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in this report.

Table of Contents

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

  • 3.1. Chapter Overview
  • 3.2. Pharmaceutical Packaging
    • 3.2.1. Types of Pharmaceutical Packaging
    • 3.2.2. Innovation in Pharmaceutical Packaging
    • 3.2.3. Traditional Aseptic Pharmaceutical Filling Operations
    • 3.2.4. Limitations of Traditional Primary Packaging
  • 3.3. Role of Containers-Closures Systems in Pharmaceutical Packaging
  • 3.4. Types of Closures Used in Pharmaceutical Packaging
    • 3.4.1. Closures for Syringes
    • 3.4.2. Closures for Vials
    • 3.4.3. Closures for Cartridges
  • 3.5. Key Considerations for Choosing Materials for Fabricating Closures
  • 3.6. Elastomeric Packaging Materials
    • 3.6.1. Key Properties of Elastomeric Packaging Materials
    • 3.6.2. Popular Types of Elastomeric Packaging Materials
    • 3.6.3. Regulatory Guidelines for Elastomeric Closures
    • 3.6.4. Manufacturing Process for Elastomeric Closures
    • 3.6.5. Quality Assessment Tests for Elastomeric Closures
    • 3.6.6. Advantages and Limitations of Elastomeric Packaging Materials
  • 3.7. Concluding Remarks

4. MARKET LANDSCAPE

  • 4.1. Chapter Overview
  • 4.2. Elastomeric Closures for Parenteral Containers: List of Products
    • 4.2.1. Analysis by Type of Closure
    • 4.2.2. Analysis by Type of Container
    • 4.2.3. Analysis by Type of Elastomeric Material
    • 4.2.4. Analysis by Type of Coating
    • 4.2.5. Analysis by Drug Class
    • 4.2.6. Analysis by Sterilization Status
    • 4.2.7. Analysis by Sterilization Technique
  • 4.3. Elastomeric Closures for Parenteral Containers: List of Manufacturers
    • 4.3.1. Analysis by Year of Establishment
    • 4.3.2. Analysis by Company Size
    • 4.3.3. Analysis by Scale of Production
    • 4.3.4. Analysis by Location of Headquarters
    • 4.3.5. Leading Manufacturers: Analysis by Number of Products
    • 4.3.6. Manufacturer Landscape: Analysis by Company Size and Location of Headquarters
  • 4.5. Elastomeric Closures for Parenteral Containers: Recent Initiatives of Players
    • 4.5.1. List of Ready-to-Use Containers-Closure Systems
  • 4.6. Concluding Remarks

5. COMPANY PROFILES

  • 5.1. Chapter Overview
  • 5.2. Key Players Based in North America
    • 5.2.1. Aptar Pharma (a Part of AptarGroup)
      • 5.2.1.1. Company Overview
      • 5.2.1.2. Financial Information
      • 5.2.1.3. Product Portfolio
      • 5.2.1.4. Recent Developments and Future Outlook
    • 5.2.2. DWK Life Sciences
      • 5.2.2.1. Company Overview
      • 5.2.2.2. Product Portfolio
      • 5.2.2.3. Recent Developments and Future Outlook
    • 5.2.3. West Pharmaceutical Services
      • 5.2.3.1. Company Overview
      • 5.2.3.2. Financial Information
      • 5.2.3.3. Product Portfolio
      • 5.2.3.4. Recent Developments and Future Outlook
  • 5.3. Key Players Based in Europe
    • 5.3.1. Datwyler Sealing Solutions (a Part of Datwyler Group)
      • 5.3.1.1. Company Overview
      • 5.3.1.2. Financial Information
      • 5.3.1.3. Product Portfolio
      • 5.3.1.4 Recent Developments and Future Outlook
    • 5.3.2. Lonstroff (a Part of Sumitomo Rubber Industries)
      • 5.3.2.1. Company Overview
      • 5.3.2.2. Financial Information
      • 5.3.2.2. Product Portfolio
      • 5.3.2.3. Recent Developments and Future Outlook
    • 5.3.3. Ompi (a Part of Stevanato Group)
      • 5.3.3.1. Company Overview
      • 5.3.3.2. Product Portfolio
      • 5.3.3.3. Recent Developments and Future Outlook
  • 5.4. Key Players Based in Asia-Pacific
    • 5.4.1 Daikyo Seiko
      • 5.4.1.1. Company Overview
      • 5.4.1.2. Product Portfolio
      • 5.4.1.3. Recent Developments and Future Outlook
    • 5.4.2. Hebei First Rubber Medical Technology (a Part of DESHENG Group)
      • 5.4.2.1. Company Overview
      • 5.4.2.2. Product Portfolio
      • 5.4.2.3. Recent Developments and Future Outlook
    • 5.4.3. Jiangsu Hualan New Pharmaceutical Material
      • 5.4.3.1. Company Overview
      • 5.4.3.2. Product Portfolio
      • 5.4.3.3. Recent Developments and Future Outlook

6. PACKAGING TRENDS ANALYSIS FOR RECENTLY APPROVED DRUGS

  • 6.1. Chapter Overview
  • 6.2. List of Approved Drugs (2014-2018)
    • 6.2.1. Analysis by Year of Approval
    • 6.2.2. Analysis by Type of Molecule
    • 6.2.3. Analysis by Type of Biologic
    • 6.2.4. Analysis by Holding Temperature Range
    • 6.2.5. Analysis by Type of Container
    • 6.2.6. Analysis by Type of Container and Year of Approval
    • 6.2.7. Analysis by Type of Container and Type of Molecule
    • 6.2.8. Analysis by Type of Container and Dosage Form
    • 6.2.9. Analysis by Type of Container and Route of Administration
    • 6.2.10. Analysis by Type of Container and Holding Temperature Range
    • 6.2.11. Popular Type of Material Used for Containers
    • 6.2.12. Analysis by Type of Closure
    • 6.2.13. Analysis by Type of Closure and Year of Approval
    • 6.2.14. Analysis by Type of Closure and Type of Molecule
    • 6.2.15. Analysis by Type of Closure and Dosage Form
    • 6.2.16. Analysis by Type of Closure and Route of Administration
    • 6.2.17. Analysis by Type of Closure and Holding Temperature Range
    • 6.2.18. Popular Type of Material Used for Closures
    • 6.2.19. Analysis by Type of Elastomeric Material Used for Closures and Dosage Form
    • 6.2.20. Analysis by Type of Elastomeric Material Used for Closures and Route of Administration
    • 6.2.21. Analysis by Type of Elastomeric Material Used for Closures and Holding Temperature Range
    • 6.2.22. Analysis by Type of Elastomeric Material Used for Closures
    • 6.2.23. Most Active Players: Analysis by Number of Drugs Packaged Using Elastomeric Closures
    • 6.2.24. Concluding Remarks

7. RECENT DEVELOPMENTS

  • 7.1. Chapter Overview
  • 7.2. Pharmaceutical Packaging Industry: Partnership Activity
    • 7.2.1. Partnership Models
    • 7.2.2. List of Partnerships and Collaborations
      • 7.2.2.1. Analysis by Year of Partnership
      • 7.2.2.2. Analysis by Type of Partnership
      • 7.2.2.3. Analysis by Focus Area
      • 7.2.2.4. Most Active Players: Analysis by Number of Partnerships
  • 7.3. Elastomeric Container Closures in Pharmaceutical Packaging Industry: Recent Expansions
  • 7.4. Pharmaceutical Packaging Industry: Recent Conferences
    • 7.4.1. List of Recent Conferences
      • 7.4.1.1. Analysis by Year of Occurrence
      • 7.4.1.2. Analysis by Geography
    • 7.4.2. Elastomeric Container Closures: List of Recent Conferences
      • 7.4.2.1. Analysis by Focus Area / Agenda
    • 7.4.3. Geographical Mapping of Conferences
  • 7.5. Concluding Remarks

8. DEMAND ANALYSIS

  • 8.1. Chapter Overview
  • 8.2. Scope and Methodology
  • 8.3. Global Demand for Elastomeric Closures, 2019-2030
    • 8.3.1. Analysis by Type of Container
      • 8.3.1.1. Global Demand for Elastomeric Closures for Vials
      • 8.3.1.2. Global Demand for Elastomeric Closures for Syringes
      • 8.3.1.3. Global Demand for Elastomeric Closures for Cartridges
    • 8.3.2. Analysis by Type of Closure
      • 8.3.2.1. Global Demand for Elastomeric Seals
      • 8.3.2.2. Global Demand for Elastomeric Stoppers
      • 8.3.2.3. Global Demand for Elastomeric Caps
      • 8.3.2.4. Global Demand for Elastomeric Plungers
      • 8.3.2.5. Global Demand for Elastomeric Barrels
      • 8.3.2.6. Global Demand for Elastomeric Needle Shields
    • 8.3.3. Analysis by Sterilization Status
      • 8.3.3.1. Global Demand for Pre-Sterilized Elastomeric Closures
        • 8.3.3.1.1. Global Demand for Pre-Sterilized Elastomeric Seals
        • 8.3.3.1.2. Global Demand for Pre-Sterilized Elastomeric Stoppers
        • 8.3.3.1.3. Global Demand for Pre-Sterilized Elastomeric Caps
        • 8.3.3.1.4. Global Demand for Pre-Sterilized Elastomeric Plungers
        • 8.3.3.1.5. Global Demand for Pre-Sterilized Elastomeric Barrels
        • 8.3.3.1.6. Global Demand for Pre-Sterilized Elastomeric Needle Shields
      • 8.3.3.2. Global Demand for Unsterilized Elastomeric Closures
        • 8.3.3.2.1. Global Demand for Unsterilized Elastomeric Seals
        • 8.3.3.2.2. Global Demand for Unsterilized Elastomeric Stoppers
        • 8.3.3.2.3. Global Demand for Unsterilized Elastomeric Caps
        • 8.3.3.2.4. Global Demand for Unsterilized Elastomeric Plungers
        • 8.3.3.2.5. Global Demand for Unsterilized Elastomeric Barrels
        • 8.3.3.2.6. Global Demand for Unsterilized Elastomeric Needle Shields
    • 8.3.4. Analysis by Geography
      • 8.3.4.1. Demand for Elastomeric Closures in North America
        • 8.3.4.1.1. Demand for Elastomeric Seals in North America
        • 8.3.4.1.2. Demand for Elastomeric Stoppers in North America
        • 8.3.4.1.3. Demand for Elastomeric Caps in North America
        • 8.3.4.1.4. Demand for Elastomeric Plungers in North America
        • 8.3.4.1.5. Demand for Elastomeric Barrels in North America
        • 8.3.4.1.6. Demand for Elastomeric Needle Shields in North America
      • 8.3.4.2. Demand for Elastomeric Closures in Europe
        • 8.3.4.2.1. Demand for Elastomeric Seals in Europe
        • 8.3.4.2.2. Demand for Elastomeric Stoppers in Europe
        • 8.3.4.2.3. Demand for Elastomeric Caps in Europe
        • 8.3.4.2.4. Demand for Elastomeric Plungers in Europe
        • 8.3.4.2.5. Demand for Elastomeric Barrels in Europe
        • 8.3.4.2.6. Demand for Elastomeric Needle Shields in Europe
      • 8.3.4.3. Demand for Elastomeric Closures in Asia-Pacific
        • 8.3.4.3.1. Demand for Elastomeric Seals in Asia-Pacific
        • 8.3.4.3.2. Demand for Elastomeric Stoppers in Asia-Pacific
        • 8.3.4.3.3. Demand for Elastomeric Caps in Asia-Pacific
        • 8.3.4.3.4. Demand for Elastomeric Plungers in Asia-Pacific
        • 8.3.4.3.5. Demand for Elastomeric Barrels in Asia-Pacific
        • 8.3.4.3.6. Demand for Elastomeric Needle Shields in Asia-Pacific
      • 8.3.4.4. Demand for Elastomeric Closures in Rest of the World
        • 8.3.4.4.1. Demand for Elastomeric Seals in Rest of the World
        • 8.3.4.4.2. Demand for Elastomeric Stoppers in Rest of the World
        • 8.3.4.4.3. Demand for Elastomeric Caps in Rest of the World
        • 8.3.4.4.4. Demand for Elastomeric Plungers in Rest of the World
        • 8.3.4.4.5. Demand for Elastomeric Barrels in Rest of the World
        • 8.3.4.4.6. Demand for Elastomeric Needle Shields in Rest of the World
  • 8.4. Concluding Remarks

9. MARKET FORECAST

  • 9.1. Chapter Overview
  • 9.2. Forecast Methodology and Key Assumptions
  • 9.3. Global Elastomeric Closures Market, 2019-2030
    • 9.3.1. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container
      • 9.3.1.1. Global Elastomeric Closures Market for Vials, 2019-2030
      • 9.3.1.2. Global Elastomeric Closures Market for Syringes, 2019-2030
      • 9.3.1.3. Global Elastomeric Closures Market for Cartridges, 2019-2030
    • 9.3.2. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure
      • 9.3.2.1. Global Elastomeric Closures Market for Seals, 2019-2030
      • 9.3.2.2. Global Elastomeric Closures Market for Stoppers, 2019-2030
      • 9.3.2.3. Global Elastomeric Closures Market for Caps, 2019-2030
      • 9.3.2.4. Global Elastomeric Closures Market for Plungers, 2019-2030
      • 9.3.2.5. Global Elastomeric Closures Market for Barrels, 2019-2030
      • 9.3.2.6. Global Elastomeric Closures Market for Needle Shields, 2019-2030
    • 9.3.3. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status
      • 9.3.3.1. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030
        • 9.3.3.1.1. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030
        • 9.3.3.1.2. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030
        • 9.3.3.1.3. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030
        • 9.3.3.1.4. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030
        • 9.3.3.1.5. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030
        • 9.3.3.1.6. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030
      • 9.3.3.2. Global Unsterilized Elastomeric Closures Market, 2019-2030
        • 9.3.3.2.1. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030
        • 9.3.3.2.2. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030
        • 9.3.3.2.3. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030
        • 9.3.3.2.4. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030
        • 9.3.3.2.5. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030
        • 9.3.3.2.6. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030
    • 9.3.4. Global Elastomeric Closures Market, 2019-2030: Distribution by Geography
      • 9.3.4.1. Elastomeric Closures Market in North America, 2019-2030
        • 9.3.4.1.1. Elastomeric Closures Market for Seals in North America, 2019-2030
        • 9.3.4.1.2. Elastomeric Closures Market for Stoppers in North America, 2019-2030
        • 9.3.4.1.3. Elastomeric Closures Market for Caps in North America, 2019-2030
        • 9.3.4.1.4. Elastomeric Closures Market for Plungers in North America, 2019-2030
        • 9.3.4.1.5. Elastomeric Closures Market for Barrels in North America, 2019-2030
        • 9.3.4.1.6. Elastomeric Closures Market for Needle Shields in North America, 2019-2030
      • 9.3.4.2. Elastomeric Closures Market in Europe, 2019-2030
        • 9.3.4.2.1. Elastomeric Closures Market for Seals in Europe, 2019-2030
        • 9.3.4.2.2. Elastomeric Closures Market for Stoppers in Europe, 2019-2030
        • 9.3.4.2.3. Elastomeric Closures Market for Caps in Europe, 2019-2030
        • 9.3.4.2.4. Elastomeric Closures Market for Plungers in Europe, 2019-2030
        • 9.3.4.2.5. Elastomeric Closures Market for Barrels in Europe, 2019-2030
        • 9.3.4.2.6. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030
      • 9.3.4.3. Elastomeric Closures Market in Asia-Pacific, 2019-2030
        • 9.3.4.3.1. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030
        • 9.3.4.3.2. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030
        • 9.3.4.3.3. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030
        • 9.3.4.3.4. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030
        • 9.3.4.3.5. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030
        • 9.3.4.3.6. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030
      • 9.3.4.4. Elastomeric Closures Market in Rest of the World, 2019-2030
        • 9.3.4.4.1. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030
        • 9.3.4.4.2. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030
        • 9.3.4.4.3. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030
        • 9.3.4.4.4. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030
        • 9.3.4.4.5. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030
        • 9.3.4.4.6. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030
  • 9.4. Concluding Remarks

10. CASE STUDY: ROBOTICS IN PHARMACEUTICAL PACKAGING

  • 10.1. Chapter Overview
  • 10.2. Role of Robots in the Pharmaceutical Industry
    • 10.2.1. Key Considerations for Selecting a Robotic System
    • 10.2.2. Advantages of Robotic Systems
    • 10.2.3. Disadvantages of Robotic Systems
  • 10.3. Companies Providing Robots for Pharmaceutical Industry
  • 10.4. Companies Providing Equipment Integrated with Robotic Systems for Pharmaceutical Packaging
    • 10.4.1. Aseptic Technologies
      • 10.4.1.1. Crystal® L1 Robot Line
      • 10.4.1.2. Crystal® SL1 Robot Line
    • 10.4.2. AST
      • 10.4.2.1. ASEPTiCell® Series
      • 10.4.2.2. ASEPTiCell® VSM-25
    • 10.4.3. Bosch Packaging Technology
      • 10.4.3.1. ATO
    • 10.4.4. Dara Pharmaceutical Packaging
      • 10.4.4.1. SYX-E CARTRIDGE + RABS
    • 10.4.5. Fedegari Group
      • 10.4.5.1. Fedegari Isolator
    • 10.4.6. IMA
      • 10.4.6.1. INJECTA
      • 10.4.6.2. STERI LIF3
    • 10.4.7. Steriline
      • 10.4.7.1. Nest Filling Line RNFM
    • 10.4.8. Vanrx Pharmasystems
      • 10.4.8.1. Microcell Vial Filler
      • 10.4.8.2. SA25 Aseptic Filling Workcell

11. EMERGING TRENDS IN PHARMACEUTICAL PACKAGING

  • 11.1. Chapter Overview
  • 11.2. Shift Towards Self-Medication using Advanced Drug Delivery Devices
  • 11.3. Focus on Developing Improved Packaging Components and Ongoing Efforts to Optimize Manufacturing Costs
  • 11.4. Availability of Modular Facilities
  • 11.5. Initiatives Focused on Automation of Fill / Finish Operations
  • 11.6. Establishment of Business Relationships Focused on Designing Compatible Packaging Materials for Various Drug Products
  • 11.7. Increasing Activity in Developing Regions
  • 11.8. Growing Adoption of Smart Packaging Solutions
  • 11.9. Concluding Remarks

12. EXECUTIVE INSIGHTS

  • 12.1. Chapter Overview
  • 12.2. Aseptic Technologies
    • 12.2.1. Company Snapshot
    • 12.2.2. Interview Transcript: Julien Maréchal, Business Development and Technology Director
  • 12.3. BioPhorum Operations Group
    • 12.3.1. Company Snapshot
    • 13.3.2. Interview Transcript: Malcolm Gilmore, Facilitator
  • 12.4. Lonstroff
    • 12.4.1. Company Snapshot
    • 12.4.2. Interview Transcript: Marco Pederiva, Marketing and Sales Director
  • 12.5. PYRAMID Laboratories
    • 12.5.1. Company Snapshot
    • 12.5.2. Interview Transcript: Konstantin Kazarian, Business Development Project Manager

13. APPENDIX 1: TABULATED DATA

14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

  • Figure 3.1. Advantages of Pharmaceutical Packaging
  • Figure 3.2. Types of Pharmaceutical Packaging
  • Figure 3.3. Innovation in Pharmaceutical Packaging
  • Figure 3.4. Traditional Aseptic Pharmaceutical Filling
  • Figure 3.5. List of Various Primary Packaging Containers-Closures Systems
  • Figure 3.6. Applications of Elastomeric Materials in Various Industries
  • Figure 3.7. Key Properties of Elastomeric Materials
  • Figure 3.8. Comparison of Different Types of Packaging Materials
  • Figure 3.9. Advantages and Limitations of Elastomeric Materials Used in Pharmaceutical Packaging Industry
  • Figure 4.1. Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure
  • Figure 4.2. Elastomeric Closures for Parenteral Containers: Distribution by Type of Container
  • Figure 4.3. Elastomeric Closures for Parenteral Containers: Distribution by Type of Elastomeric Material
  • Figure 4.4. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Status
  • Figure 4.5. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Technique
  • Figure 4.6. Elastomeric Closures for Parenteral Containers: Distribution by Type of Coating
  • Figure 4.7. Elastomeric Closures for Parenteral Containers: Distribution by Drug Class
  • Figure 4.8. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Year of Establishment
  • Figure 4.9. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Company Size
  • Figure 4.10. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Scale of Production
  • Figure 4.11. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Location of Headquarters
  • Figure 4.12. Leading Manufacturers: Distribution by Number of Products
  • Figure 4.13. Manufacturer Landscape: Distribution by Company Size and Location of Headquarters
  • Figure 5.1. AptarGroup: Annual Revenues, 2013-Q3 2018 (USD Billion)
  • Figure 5.2. West Pharmaceutical Services: Annual Revenues, 2013-2018 (USD Billion)
  • Figure 5.3. Datwyler Group: Annual Revenues, 2013-2018 (CHF Million)
  • Figure 5.4. Sumitomo Rubber Industries: Annual Revenues, 2013-2018 (Yen Billion)
  • Figure 5.5. Sumitomo Rubber Industries: Annual Revenues by Business Segments, 2018
  • Figure 6.1. Approved Drugs (2014-2018): Distribution by Year of Approval
  • Figure 6.2. Approved Drugs (2014-2018): Distribution by Type of Molecule
  • Figure 6.3. Approved Drugs (2014-2018): Distribution by Type of Biologic
  • Figure 6.4. Approved Drugs (2014-2018): Distribution by Holding Temperature Range
  • Figure 6.5. Approved Drugs (2014-2018): Distribution by Type of Container
  • Figure 6.6. Approved Drugs (2014-2018): Distribution by Type of Container and Year of Approval
  • Figure 6.7. Approved Drugs (2014-2018): Distribution by Type of Container and Type of Molecule
  • Figure 6.8. Approved Drugs (2014-2018): Distribution by Type of Container and Dosage Form
  • Figure 6.9. Approved Drugs (2014-2018): Distribution by Type of Container and Route of Administration
  • Figure 6.10. Approved Drugs (2014-2018): Distribution by Type of Container and Holding Temperature Range
  • Figure 6.11. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Biologics
  • Figure 6.12. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Small Molecule
  • Figure 6.13. Approved Drugs (2014-2018): Distribution by Type of Closure
  • Figure 6.14. Approved Drugs (2014-2018): Distribution by Type of Closure and Year of Approval
  • Figure 6.15. Approved Drugs (2014-2018): Distribution by Type of Closure and Type of Molecule
  • Figure 6.16. Approved Drugs (2014-2018): Distribution by Type of Closure and Dosage Form
  • Figure 6.17. Approved Drugs (2014-2018): Distribution by Type of Closure and Route of Administration
  • Figure 6.18. Approved Drugs (2014-2018): Distribution by Type of Closure and Holding Temperature Range
  • Figure 6.19. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Biologics
  • Figure 6.20. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Small Molecules
  • Figure 6.21. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Dosage Form
  • Figure 6.22. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Route of Administration
  • Figure 6.23. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Holding Temperature Range
  • Figure 6.24. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures
  • Figure 6.25. Most Active Players: Distribution by Number of Drugs Packaged using Elastomeric Closures
  • Figure 6.26. Approved Drugs (2014-2018), Grid Analysis: Distribution by Type of Container, Closure, Type of Material and Route of Administration
  • Figure 6.27. Approved Drugs (2014-2018), Bubble Analysis: Distribution by Type of Closure, Type of Elastomeric Material and Type of Molecule
  • Figure 7.1. Partnerships and Collaborations: Cumulative Trend by Year, Pre-2015-2019
  • Figure 7.2. Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 7.3. Partnerships and Collaborations: Distribution by Focus Area
  • Figure 7.4. Partnerships and Collaborations: Most Active Players
  • Figure 7.5. Global Conferences: Cumulative Year-Wise Trend, 2015-2019
  • Figure 7.6. Global Conferences: Distribution by Location
  • Figure 7.7. Global Conferences Related to Elastomeric Containers Closures: Key Focus Areas
  • Figure 7.8. Global Conferences: Geographical Mapping
  • Figure 8.1. Global Demand for Elastomeric Closures: Methodology and Key Assumptions
  • Figure 8.2. Global Demand for Elastomeric Closures, 2019-2030 (Billion Units)
  • Figure 8.3. Global Demand for Elastomeric Closures: Distribution by Type of Container, 2019 and 2030
  • Figure 8.4. Global Demand for Elastomeric Closures for Vials, 2019-2030 (Billion Units)
  • Figure 8.5. Global Demand for Elastomeric Closures for Syringes, 2019-2030 (Billion Units)
  • Figure 8.6. Global Demand for Elastomeric Closures for Cartridges, 2019-2030 (Billion Units)
  • Figure 8.7. Global Demand for Elastomeric Closures: Distribution by Type of Closure, 2019 and 2030
  • Figure 8.8. Global Demand for Elastomeric Seals, 2019-2030 (Billion Units)
  • Figure 8.9. Global Demand for Elastomeric Stoppers, 2019-2030 (Billion Units)
  • Figure 8.10. Global Demand for Elastomeric Caps, 2019-2030 (Billion Units)
  • Figure 8.11. Global Demand for Elastomeric Plungers, 2019-2030 (Billion Units)
  • Figure 8.12. Global Demand for Elastomeric Barrels, 2019-2030 (Billion Units)
  • Figure 8.13. Global Demand for Elastomeric Needle Shields, 2019-2030 (Billion Units)
  • Figure 8.14. Global Demand for Elastomeric Closures: Distribution by Sterilization Status, 2019 and 2030
  • Figure 8.15. Global Demand for Elastomeric Pre-Sterilized Elastomeric Closures, 2019-2030 (Billion Units)
  • Figure 8.16. Global Demand for Elastomeric Pre-Sterilized Elastomeric Seals, 2019-2030 (Billion Units)
  • Figure 8.17. Global Demand for Elastomeric Pre-Sterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
  • Figure 8.18. Global Demand for Elastomeric Pre-Sterilized Elastomeric Caps, 2019-2030 (Billion Units)
  • Figure 8.19. Global Demand for Elastomeric Pre-Sterilized Elastomeric Plungers, 2019-2030 (Billion Units)
  • Figure 8.20. Global Demand for Elastomeric Pre-Sterilized Elastomeric Barrels, 2019-2030 (Billion Units)
  • Figure 8.21. Global Demand for Elastomeric Pre-Sterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
  • Figure 8.22. Global Demand for Elastomeric Unsterilized Elastomeric Closures, 2019-2030 (Billion Units)
  • Figure 8.23. Global Demand for Elastomeric Unsterilized Elastomeric Seals, 2019-2030 (Billion Units)
  • Figure 8.24. Global Demand for Elastomeric Unsterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
  • Figure 8.25. Global Demand for Elastomeric Unsterilized Elastomeric Caps, 2019-2030 (Billion Units)
  • Figure 8.26. Global Demand for Elastomeric Unsterilized Elastomeric Plungers, 2019-2030 (Billion Units)
  • Figure 8.27. Global Demand for Elastomeric Unsterilized Elastomeric Barrels, 2019-2030 (Billion Units)
  • Figure 8.28. Global Demand for Elastomeric Unsterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
  • Figure 8.29. Global Demand for Elastomeric Closures: Distribution by Geography, 2019 and 2030
  • Figure 8.30. Demand for Elastomeric Seals in North America, 2019-2030 (Billion Units)
  • Figure 8.31. Demand for Elastomeric Stoppers in North America, 2019-2030 (Billion Units)
  • Figure 8.32. Demand for Elastomeric Caps in North America, 2019-2030 (Billion Units)
  • Figure 8.33. Demand for Elastomeric Plungers in North America, 2019-2030 (Billion Units)
  • Figure 8.34. Demand for Elastomeric Barrels in North America, 2019-2030 (Billion Units)
  • Figure 8.35. Demand for Elastomeric Needle Shields in North America, 2019-2030 (Billion Units)
  • Figure 8.36. Demand for Elastomeric Closures in Europe, 2019-2030 (Billion Units)
  • Figure 8.37. Demand for Elastomeric Seals in Europe, 2019-2030 (Billion Units)
  • Figure 8.38. Demand for Elastomeric Stoppers in Europe, 2019-2030 (Billion Units)
  • Figure 8.39. Demand for Elastomeric Caps in Europe, 2019-2030 (Billion Units)
  • Figure 8.40. Demand for Elastomeric Plungers in Europe, 2019-2030 (Billion Units)
  • Figure 8.41. Demand for Elastomeric Barrels in Europe, 2019-2030 (Billion Units)
  • Figure 8.42. Demand for Elastomeric Needle Shields in Europe, 2019-2030 (Billion Units)
  • Figure 8.43. Demand for Elastomeric Closures in Asia-Pacific, 2019-2030 (Billion Units)
  • Figure 8.44. Demand for Elastomeric Seals in Asia-Pacific, 2019-2030 (Billion Units)
  • Figure 8.45. Demand for Elastomeric Stoppers in Asia-Pacific, 2019-2030 (Billion Units)
  • Figure 8.46. Demand for Elastomeric Caps in Asia-Pacific, 2019-2030 (Billion Units)
  • Figure 8.47. Demand for Elastomeric Plungers in Asia-Pacific, 2019-2030 (Billion Units)
  • Figure 8.48. Demand for Elastomeric Barrels in Asia-Pacific, 2019-2030 (Billion Units)
  • Figure 8.49. Demand for Elastomeric Needle Shields in Asia-Pacific, 2019-2030 (Billion Units)
  • Figure 8.50. Demand for Elastomeric Closures in Rest of the World, 2019-2030 (Billion Units)
  • Figure 8.51. Demand for Elastomeric Seals in Rest of the World, 2019-2030 (Billion Units)
  • Figure 8.52. Demand for Elastomeric Stoppers in Rest of the World, 2019-2030 (Billion Units)
  • Figure 8.53. Demand for Elastomeric Caps in Rest of the World, 2019-2030 (Billion Units)
  • Figure 8.54. Demand for Elastomeric Plungers in Rest of the World, 2019-2030 (Billion Units)
  • Figure 8.55. Demand for Elastomeric Barrels in Rest of the World, 2019-2030 (Billion Units)
  • Figure 8.56. Demand for Elastomeric Needle Shields in Rest of the World, 2019-2030 (Billion Units)
  • Figure 9.1. Global Elastomeric Closures Market: Forecast Methodology and Key Assumptions
  • Figure 9.2. Global Elastomeric Closures Market, 2019-2030 (USD Billion)
  • Figure 9.3. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container (USD Billion)
  • Figure 9.4. Global Elastomeric Closures Market for Vials, 2019-2030 (USD Billion)
  • Figure 9.5. Global Elastomeric Closures Market for Syringes, 2019-2030 (USD Billion)
  • Figure 9.6. Global Elastomeric Closures Market for Cartridges, 2019-2030 (USD Billion)
  • Figure 9.7. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure (USD Billion)
  • Figure 9.8. Global Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
  • Figure 9.9. Global Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
  • Figure 9.10. Global Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
  • Figure 9.11. Global Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
  • Figure 9.12. Global Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
  • Figure 9.13. Global Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Billion)
  • Figure 9.14. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status (USD Billion)
  • Figure 9.15. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030 (USD Billion)
  • Figure 9.16. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
  • Figure 9.17. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
  • Figure 9.18. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
  • Figure 9.19. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
  • Figure 9.20. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
  • Figure 9.21. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Billion)
  • Figure 9.22. Global Unsterilized Elastomeric Closures Market, 2019-2030 (USD Billion)
  • Figure 9.23. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030 (USD Billion)
  • Figure 9.24. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030 (USD Billion)
  • Figure 9.25. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030 (USD Billion)
  • Figure 9.26. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030 (USD Billion)
  • Figure 9.27. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030 (USD Billion)
  • Figure 9.28. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030 (USD Billion)
  • Figure 9.29. Elastomeric Closures Market, 2019-2030: Distribution by Geography (USD Billion)
  • Figure 9.30. Elastomeric Closures Market in North America, 2019-2030 (USD Billion)
  • Figure 9.31. Elastomeric Closures Market for Seals in North America, 2019-2030 (USD Billion)
  • Figure 9.32. Elastomeric Closures Market for Stoppers in North America, 2019-2030 (USD Billion)
  • Figure 9.33. Elastomeric Closures Market for Caps in North America, 2019-2030 (USD Billion)
  • Figure 9.34. Elastomeric Closures Market for Plungers in North America, 2019-2030 (USD Billion)
  • Figure 9.35. Elastomeric Closures Market for Barrels in North America, 2019-2030 (USD Billion)
  • Figure 9.36. Elastomeric Closures Market for Needle Shields in North America, 2019-2030 (USD Billion)
  • Figure 9.37. Elastomeric Closures Market in Europe, 2019-2030 (USD Billion)
  • Figure 9.38. Elastomeric Closures Market for Seals in Europe, 2019-2030 (USD Billion)
  • Figure 9.39. Elastomeric Closures Market for Stoppers in Europe, 2019-2030 (USD Billion)
  • Figure 9.40. Elastomeric Closures Market for Caps in Europe, 2019-2030 (USD Billion)
  • Figure 9.41. Elastomeric Closures Market for Plungers in Europe, 2019-2030 (USD Billion)
  • Figure 9.42. Elastomeric Closures Market for Barrels in Europe, 2019-2030 (USD Billion)
  • Figure 9.43. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030 (USD Billion)
  • Figure 9.44. Elastomeric Closures Market in Asia-Pacific, 2019-2030 (USD Billion)
  • Figure 9.45. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030 (USD Billion)
  • Figure 9.46. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030 (USD Billion)
  • Figure 9.47. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030 (USD Billion)
  • Figure 9.48. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030 (USD Billion)
  • Figure 9.49. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030 (USD Billion)
  • Figure 9.50. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030 (USD Billion)
  • Figure 9.51. Elastomeric Closures Market in Rest of the World, 2019-2030 (USD Billion)
  • Figure 9.52. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030 (USD Billion)
  • Figure 9.53. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030 (USD Billion)
  • Figure 9.54. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030 (USD Billion)
  • Figure 9.55. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030 (USD Billion)
  • Figure 9.56. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030 (USD Billion)
  • Figure 9.57. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030 (USD Billion)
  • Figure 9.58. Overall Elastomeric Closures Market: Conservative, Base and Optimistic Scenario, 2019, 2024 and 2030 (USD Billion)
  • Figure 10.1. Key Considerations to Select a Robot
  • Figure 10.2. Advantages of Robotic Systems in Pharmaceutical Operations
  • Figure 11.1. Emerging Trends Related to Pharmaceutical Packaging
  • Figure 11.2. Future Growth Opportunities Related to Elastomeric Closures

List of Tables

  • Table 3.1. Key Components of Syringes
  • Table 3.2. Popular Types of Elastomeric Packaging Materials
  • Table 3.3. Popular Coatings / Surface Treatment Methods Used for Elastomeric Closures
  • Table 4.1. List of Elastomeric Closures for Parenteral Containers
  • Table 4.2. Elastomeric Closures for Parenteral Containers: Information on Type of Container
  • Table 4.3. Elastomeric Closures for Parenteral Containers: Information on Type of Elastomeric Material and Type of Drug Class
  • Table 4.4. Elastomeric Closures for Parenteral Containers: Information on Sterilization Status
  • Table 4.5. Elastomeric Closures for Parenteral Containers: Additional Information
  • Table 4.6. Elastomeric Closures for Parenteral Containers: Information on Manufacturers
  • Table 4.7. Elastomeric Closures for Parenteral Containers: Information on Scale of Operation of Manufacturers
  • Table 4.8. List of Ready-to-Use Containers-Closures Systems
  • Table 5.1. AptarGroup: Company Overview
  • Table 5.2. Aptar Pharma: Product Details
  • Table 5.3. AptarGroup: Recent Developments and Future Outlook
  • Table 5.4. DWK Life Sciences: Company Overview
  • Table 5.5. DWK Life Sciences: Product Details
  • Table 5.6. DWK Life Sciences: Recent Developments and Future Outlook
  • Table 5.7. West Pharmaceutical Services: Company Overview
  • Table 5.8. West Pharmaceutical Services: Product Details
  • Table 5.9. West Pharmaceutical Services: Recent Developments and Future Outlook
  • Table 5.10. Datwyler Sealing Solutions (a Part of Datwyler Group): Company Overview
  • Table 5.11. Datwyler Sealing Solutions (a Part of Datwyler Group): Product Details
  • Table 5.12. Datwyler Sealing Solutions (a Part of Datwyler Group) : Recent Developments and Future Outlook
  • Table 5.13. Lonstroff: Company Overview
  • Table 5.14. Sumitomo Rubber Industries: Company Overview
  • Table 5.15. Lonstroff: Product Details
  • Table 5.16. Sumitomo Rubber Industries: Recent Developments and Future Outlook
  • Table 5.17. Ompi (a Part of Stevanato Group): Company Overview
  • Table 5.18. Ompi (a Part of Stevanato Group): Product Details
  • Table 5.19. Ompi (a Part of Stevanato Group): Recent Developments and Future Outlook
  • Table 5.20. Daikyo Seiko: Company Overview
  • Table 5.21. Daikyo Seiko: Product Details
  • Table 5.22. Daikyo Seiko: Recent Developments and Future Outlook
  • Table 5.23. Hebei First Rubber Medical Technology: Company Overview
  • Table 5.24. Hebei First Rubber Medical Technology: Product Details
  • Table 5.25. Jiangsu Hualan New Pharmaceutical Material: Company Overview
  • Table 5.26. Jiangsu Hualan New Pharmaceutical Material: Product Details
  • Table 6.1. List of Approved Drugs (2014-2018): Information on Dosage Form, Route of Administration and Holding Temperature Range
  • Table 6.2. List of Approved Drugs (2014-2018): Information on Type of Container and Container Material
  • Table 6.3. List of Approved Drugs (2014-2018): Information on Type of Closure and Closure Material
  • Table 7.1. List of Partnerships and Collaborations: Information on Year and Type, 2007-2019
  • Table 7.2. List of Partnerships and Collaborations: Information on Focus Area and Product Type, 2007-2019
  • Table 7.3. List of Recent Expansions, 2014-2018
  • Table 7.4. Pharmaceutical Packaging Industry: List of Conferences, 2013-2019
  • Table 7.5. Conferences Related to Elastomeric Containers Closures: Information of Focus Area / Agenda
  • Table 7.6. Conferences Related to Elastomeric Containers Closures: Information on Key Speakers
  • Table 10.1. Pharmaceutical Robotics Manufacturers
  • Table 10.2. Aseptic Technologies: Company Overview
  • Table 10.3. Aseptic Technologies: Key Specifications of Crystal® L1 Robot Line
  • Table 10.4. Aseptic Technologies: Key Specifications of Crystal® SL1 Robot Line
  • Table 10.5. AST: Company Overview
  • Table 10.6. AST: Key Specifications of ASEPTiCell® Series
  • Table 10.7. AST: Key Specifications of ASEPTiCell® VSM-25
  • Table 10.8. Bosch Packaging Technology: Company Overview
  • Table 10.9. Bosch Packaging Technology: Key Specifications of ATO
  • Table 10.10. Dara Pharmaceutical Packaging: Company Overview
  • Table 10.11. Dara Pharmaceutical Packaging: Key Specifications of SYX-E CARTRIDGE + RABS
  • Table 10.12. Fedegari Group: Company Overview
  • Table 10.13. Fedegari Group: Key Specifications of Fedegari Isolator
  • Table 10.14. IMA: Company Overview
  • Table 10.15. IMA: Key Specifications of INJECTA
  • Table 10.16. IMA: Key Specifications of STERI LIF3
  • Table 10.17. Steriline: Company Overview
  • Table 10.18. Steriline: Key Specifications of Nest Filling Line RNFM
  • Table 10.19. Vanrx Pharmasystems: Company Overview
  • Table 10.20. Vanrx Pharmasystems: Key Specifications of Microcell Vial Filler
  • Table 10.21. Vanrx Pharmasystems: Key Specifications of SA25 Aseptic Filling Workcell
  • Table 12.1. Aseptic Technologies: Company Snapshot
  • Table 12.2. BioPhorum Operations Group: Company Snapshot
  • Table 12.3. Lonstroff: Company Snapshot
  • Table 12.4. PYRAMID Laboratories: Company Snapshot
  • Table 13.1. Elastomeric Closures for Parenteral Containers: Distribution by Type of Closure
  • Table 13.2. Elastomeric Closures for Parenteral Containers: Distribution by Type of Container
  • Table 13.3. Elastomeric Closures for Parenteral Containers: Distribution by Type of Elastomeric Material
  • Table 13.4. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Status
  • Table 13.5. Elastomeric Closures for Parenteral Containers: Distribution by Sterilization Technique
  • Table 13.6. Elastomeric Closures for Parenteral Containers: Distribution by Type of Coating
  • Table 13.7. Elastomeric Closures for Parenteral Containers: Distribution by Type of Drug Class
  • Table 13.8. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Year of Establishment
  • Table 13.9. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Company Size
  • Table 13.10. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Scale of Production
  • Table 13.11. Elastomeric Closures for Parenteral Containers: Distribution of Manufacturers by Location of Headquarters
  • Table 13.12. Leading Manufacturers: Distribution by Number of Products
  • Table 13.13. AptarGroup: Annual Revenues, 2013-Q3 2018 (USD Billion)
  • Table 13.14. West Pharmaceutical Services: Annual Revenues, 2013-2018 (USD Billion)
  • Table 13.15. Datwyler Group: Annual Revenues, 2013-2018 (CHF Million)
  • Table 13.16. Sumitomo Rubber Industries: Annual Revenues, 2013-2018 (Yen Billion)
  • Table 13.17. Sumitomo Rubber Industries: Annual Revenues by Business Segment, 2018
  • Table 13.18. Approved Drugs (2014-2018): Distribution by Year of Approval
  • Table 13.19. Approved Drugs (2014-2018): Distribution by Type of Molecule
  • Table 13.20. Approved Drugs (2014-2018): Distribution by Type of Biologic
  • Table 13.21. Approved Drugs (2014-2018): Distribution by Holding Temperature Range
  • Table 13.22. Approved Drugs (2014-2018): Distribution by Type of Container
  • Table 13.23. Approved Drugs (2014-2018): Distribution by Type of Container and Year of Approval
  • Table 13.24. Approved Drugs (2014-2018): Distribution by Type of Container and Type of Molecule
  • Table 13.25. Approved Drugs (2014-2018): Distribution by Type of Container and Dosage Form
  • Table 13.26. Approved Drugs (2014-2018): Distribution by Type of Container and Route of Administration
  • Table 13.27. Approved Drugs (2014-2018): Distribution by Type of Container and Holding Temperature Range
  • Table 13.28. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Biologics
  • Table 13.29. Approved Drugs (2014-2018): Popular Type of Material Used for Containers in Small Molecule
  • Table 13.30. Approved Drugs (2014-2018): Distribution by Type of Closure
  • Table 13.31. Approved Drugs (2014-2018): Distribution by Type of Closure and Year of Approval
  • Table 13.32. Approved Drugs (2014-2018): Distribution by Type of Closure and Type of Molecule
  • Table 13.33. Approved Drugs (2014-2018): Distribution by Type of Closure and Dosage Form
  • Table 13.34. Approved Drugs (2014-2018): Distribution by Type of Closure and Route of Administration
  • Table 13.35. Approved Drugs (2014-2018): Distribution by Type of Closure and Holding Temperature Range
  • Table 13.36. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Biologics
  • Table 13.37. Approved Drugs (2014-2018): Popular Type of Material Used for Closures in Small Molecules
  • Table 13.38. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Dosage Form
  • Table 13.39. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Route of Administration
  • Table 13.40. Approved Drugs (2014-2018): Distribution by Type of Elastomeric Material Used for Closures and Holding Temperature Range
  • Table 13.41. Approved Drugs (2014-2018): Distribution by Types of Elastomeric Material Used for Closures
  • Table 13.42. Most Active Players: Distribution by Number of Drugs Packaged Using Elastomeric Closures
  • Table 13.43. Partnerships and Collaborations: Cumulative Trend by Year, Pre-2015-2019
  • Table 13.44. Partnerships and Collaborations: Distribution by Type of Partnership
  • Table 13.45. Partnerships and Collaborations: Distribution by Focus Area
  • Table 13.46. Partnerships and Collaborations: Most Active Players
  • Table 13.47. Global Conferences: Cumulative Year-Wise Trend, 2015-2019
  • Table 13.48. Global Conferences: Distribution by Location
  • Table 13.49. Global Demand for Elastomeric Closures, 2019-2030 (Billion Units)
  • Table 13.50. Global Demand for Elastomeric Closures: Distribution by Type of Container, 2019 and 2030
  • Table 13.51. Global Demand for Elastomeric Closures for Vials, 2019-2030 (Billion Units)
  • Table 13.52. Global Demand for Elastomeric Closures for Syringes, 2019-2030 (Billion Units)
  • Table 13.53. Global Demand for Elastomeric Closures for Cartridges, 2019-2030 (Billion Units)
  • Table 13.54. Global Demand for Elastomeric Closures: Distribution by Type of Closure, 2019 and 2030
  • Table 13.55. Global Demand for Elastomeric Seals, 2019-2030 (Billion Units)
  • Table 13.56. Global Demand for Elastomeric Stoppers, 2019-2030 (Billion Units)
  • Table 13.57. Global Demand for Elastomeric Caps, 2019-2030 (Billion Units)
  • Table 13.58. Global Demand for Elastomeric Plungers, 2019-2030 (Billion Units)
  • Table 13.59. Global Demand for Elastomeric Barrels, 2019-2030 (Billion Units)
  • Table 13.60. Global Demand for Elastomeric Needle Shields, 2019-2030 (Billion Units)
  • Table 13.61. Global Demand for Elastomeric Closures: Distribution by Sterilization Status, 2019 and 2030
  • Table 13.62. Global Demand for Elastomeric Pre-Sterilized Elastomeric Closures, 2019-2030 (Billion Units)
  • Table 13.63. Global Demand for Elastomeric Pre-Sterilized Elastomeric Seals, 2019-2030 (Billion Units)
  • Table 13.64. Global Demand for Elastomeric Pre-Sterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
  • Table 13.65. Global Demand for Elastomeric Pre-Sterilized Elastomeric Caps, 2019-2030 (Billion Units)
  • Table 13.66. Global Demand for Elastomeric Pre-Sterilized Elastomeric Plungers, 2019-2030 (Billion Units)
  • Table 13.67. Global Demand for Elastomeric Pre-Sterilized Elastomeric Barrels, 2019-2030 (Billion Units)
  • Table 13.68. Global Demand for Elastomeric Pre-Sterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
  • Table 13.69. Global Demand for Elastomeric Unsterilized Elastomeric Closures, 2019-2030 (Billion Units)
  • Table 13.70. Global Demand for Elastomeric Unsterilized Elastomeric Seals, 2019-2030 (Billion Units)
  • Table 13.71. Global Demand for Elastomeric Unsterilized Elastomeric Stoppers, 2019-2030 (Billion Units)
  • Table 13.72. Global Demand for Elastomeric Unsterilized Elastomeric Caps, 2019-2030 (Billion Units)
  • Table 13.73. Global Demand for Elastomeric Unsterilized Elastomeric Plungers, 2019-2030 (Billion Units)
  • Table 13.74. Global Demand for Elastomeric Unsterilized Elastomeric Barrels, 2019-2030 (Billion Units)
  • Table 13.75. Global Demand for Elastomeric Unsterilized Elastomeric Needle Shields, 2019-2030 (Billion Units)
  • Table 13.76. Global Demand for Elastomeric Closures: Distribution by Geography, 2019 and 2030
  • Table 13.77. Demand for Elastomeric Seals in North America, 2019-2030 (Billion Units)
  • Table 13.78. Demand for Elastomeric Stoppers in North America, 2019-2030 (Billion Units)
  • Table 13.79. Demand for Elastomeric Caps in North America, 2019-2030 (Billion Units)
  • Table 13.80. Demand for Elastomeric Plungers in North America, 2019-2030 (Billion Units)
  • Table 13.81. Demand for Elastomeric Barrels in North America, 2019-2030 (Billion Units)
  • Table 13.82. Demand for Elastomeric Needle Shields in North America, 2019-2030 (Billion Units)
  • Table 13.83. Demand for Elastomeric Closures in Europe, 2019-2030 (Billion Units)
  • Table 13.84. Demand for Elastomeric Seals in Europe, 2019-2030 (Billion Units)
  • Table 13.85. Demand for Elastomeric Stoppers in Europe, 2019-2030 (Billion Units)
  • Table 13.86. Demand for Elastomeric Caps in Europe, 2019-2030 (Billion Units)
  • Table 13.87. Demand for Elastomeric Plungers in Europe, 2019-2030 (Billion Units)
  • Table 13.88. Demand for Elastomeric Barrels in Europe, 2019-2030 (Billion Units)
  • Table 13.89. Demand for Elastomeric Needle Shields in Europe, 2019-2030 (Billion Units)
  • Table 13.90. Demand for Elastomeric Closures in Asia-Pacific, 2019-2030 (Billion Units)
  • Table 13.91. Demand for Elastomeric Seals in Asia-Pacific, 2019-2030 (Billion Units)
  • Table 13.92. Demand for Elastomeric Stoppers in Asia-Pacific, 2019-2030 (Billion Units)
  • Table 13.93. Demand for Elastomeric Caps in Asia-Pacific, 2019-2030 (Billion Units)
  • Table 13.94. Demand for Elastomeric Plungers in Asia-Pacific, 2019-2030 (Billion Units)
  • Table 13.95. Demand for Elastomeric Barrels in Asia-Pacific, 2019-2030 (Billion Units)
  • Table 13.96. Demand for Elastomeric Needle Shields in Asia-Pacific, 2019-2030 (Billion Units)
  • Table 13.97. Demand for Elastomeric Closures in Rest of the World, 2019-2030 (Billion Units)
  • Table 13.98. Demand for Elastomeric Seals in Rest of the World, 2019-2030 (Billion Units)
  • Table 13.99. Demand for Elastomeric Stoppers in Rest of the World, 2019-2030 (Billion Units)
  • Table 13.100. Demand for Elastomeric Caps in Rest of the World, 2019-2030 (Billion Units)
  • Table 13.101. Demand for Elastomeric Plungers in Rest of the World, 2019-2030 (Billion Units)
  • Table 13.102. Demand for Elastomeric Barrels in Rest of the World, 2019-2030 (Billion Units)
  • Table 13.103. Demand for Elastomeric Needle Shields in Rest of the World, 2019-2030 (Billion Units)
  • Table 13.104. Global Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.105. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Primary Container (USD Billion)
  • Table 13.106. Global Elastomeric Closures Market for Vials, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.107. Global Elastomeric Closures Market for Syringes, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.108. Global Elastomeric Closures Market for Cartridges, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.109. Global Elastomeric Closures Market, 2019-2030: Distribution by Type of Closure (USD Billion)
  • Table 13.110. Global Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.111. Global Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.112. Global Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.113. Global Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.114. Global Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.115. Global Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.116. Global Elastomeric Closures Market, 2019-2030: Distribution by Sterilization Status (USD Billion)
  • Table 13.117. Global Pre-Sterilized Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.118. Global Pre-Sterilized Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.119. Global Pre-Sterilized Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.120. Global Pre-Sterilized Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.121. Global Pre-Sterilized Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.122. Global Pre-Sterilized Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.123. Global Pre-Sterilized Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.124. Global Unsterilized Elastomeric Closures Market, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.125. Global Unsterilized Elastomeric Closures Market for Seals, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.126. Global Unsterilized Elastomeric Closures Market for Stoppers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.127. Global Unsterilized Elastomeric Closures Market for Caps, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.128. Global Unsterilized Elastomeric Closures Market for Plungers, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.129. Global Unsterilized Elastomeric Closures Market for Barrels, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.130. Global Unsterilized Elastomeric Closures Market for Needle Shields, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.131. Global Elastomeric Closures Market, 2019-2030: Distribution by Geography (USD Billion)
  • Table 13.132. Elastomeric Closures Market in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.133. Elastomeric Closures Market for Seals in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.134. Elastomeric Closures Market for Stoppers in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.135. Elastomeric Closures Market for Caps in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.136. Elastomeric Closures Market for Plungers in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.137. Elastomeric Closures Market for Barrels in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.138. Elastomeric Closures Market for Needle Shields in North America, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.139. Elastomeric Closures Market in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.140. Elastomeric Closures Market for Seals in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.141. Elastomeric Closures Market for Stoppers in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.142. Elastomeric Closures Market for Caps in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.143. Elastomeric Closures Market for Plungers in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.144. Elastomeric Closures Market for Barrels in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.145. Elastomeric Closures Market for Needle Shields in Europe, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.146. Elastomeric Closures Market in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.147. Elastomeric Closures Market for Seals in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.148. Elastomeric Closures Market for Stoppers in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.149. Elastomeric Closures Market for Caps in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.150. Elastomeric Closures Market for Plungers in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.151. Elastomeric Closures Market for Barrels in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.152. Elastomeric Closures Market for Needle Shields in Asia-Pacific, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.153. Elastomeric Closures Market in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.154. Elastomeric Closures Market for Seals in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.155. Elastomeric Closures Market for Stoppers in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.156. Elastomeric Closures Market for Caps in Rest of the World, 2019-2030 (USD Billion)
  • Table 13.157. Elastomeric Closures Market for Plungers in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.158. Elastomeric Closures Market for Barrels in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)
  • Table 13.159. Elastomeric Closures Market for Needle Shields in Rest of the World, 2019-2030: Conservative, Base and Optimistic Scenarios (USD Billion)

Listed Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  • 1. ABB
  • 2. AbbVie
  • 3. Abu Dhabi Polytechnic
  • 4. ACADIA Pharmaceuticals
  • 5. Accurate Elastomer Products
  • 6. AcelRx Pharmaceuticals
  • 7. Achaogen
  • 8. Acme Vial and Glass
  • 9. Acorda Therapeutics
  • 10. Actelion Pharmaceuticals
  • 11. Advanced Accelerator Applications
  • 12. AdvantaPure
  • 13. Aerie Pharmaceuticals
  • 14. Afton Scientific
  • 15. Agios Pharmaceuticals
  • 16. AkaRx
  • 17. Akcea Therapeutics
  • 18. Alcon Laboratories
  • 19. Alexion Pharmaceuticals
  • 20. Alkermes
  • 21. Allergan
  • 22. Allergy Laboratories
  • 23. Almirall
  • 24. Amcor
  • 25. Amgen
  • 26. Amphastar Pharmaceuticals
  • 27. Anacor Pharmaceuticals
  • 28. Anhui Huafeng Pharmaceutical Rubber
  • 29. Anhui Zhongma Rubber & Plastic Products
  • 30. Antares Pharma
  • 31. APG Europe
  • 32. API Pharma
  • 33. Aptar CSP Technologies
  • 34. Aptar Pharma
  • 35. Aquestive Therapeutics
  • 36. ARaymond Life
  • 37. Ariad Pharmaceuticals
  • 38. ARLANXEO
  • 39. Array BioPharma
  • 40. Aseptic Technologies
  • 41. Assem-Pak
  • 42. Astellas Pharma
  • 43. AstraZeneca
  • 44. Automated Systems of Tacoma (AST)
  • 45. Balda Group (part of Stevanato Group)
  • 46. Bausch & Lomb
  • 47. Bausch Health
  • 48. Bayer
  • 49. Becton Dickinson
  • 50. Berry Global
  • 51. Bespak
  • 52. Bharat Rubber Works
  • 53. BioCryst Pharmaceuticals
  • 54. Biogen
  • 55. BioMarin Pharmaceutical
  • 56. BioPhorum Operations Group
  • 57. Black Frame Advisors
  • 58. BloodWorks Northwest
  • 59. Blue Earth
  • 60. Boehringer Ingelheim
  • 61. Bosch Packaging Technology
  • 62. Bracco Diagnostics
  • 63. Bright Indotech
  • 64. Bristol-Myers Squibb (BMS)
  • 65. BV Holdings
  • 66. C Otto Gehrckens
  • 67. Caps and Seals
  • 68. Catalyst Pharmaceuticals
  • 69. Celgene
  • 70. Celltrion
  • 71. Chelsea Therapeutics
  • 72. Chemo Research
  • 73. Chiesi USA
  • 74. Ciron Drugs
  • 75. Cixi Lixin Rubber
  • 76. Cleveland Cord Blood Center
  • 77. Clovis Oncology
  • 78. Cole-Parmer
  • 79. Columbia Engineered Rubber
  • 80. Corning
  • 81. Cosmo Pharmaceuticals
  • 82. CSPC Pharmaceutical Group
  • 83. Cubist Pharmaceuticals
  • 84. Daiichi Sankyo
  • 85. Daikyo Seiko
  • 86. Danyang Jincheng Medical Rubber & Plastics
  • 87. Dara Pharmaceutical Packaging
  • 88. Datwyler Sealing Solutions
  • 89. Dayou Trading
  • 90. Debiotech
  • 91. DENSO
  • 92. Dow Corning
  • 93. DowDuPont Specialty Products (DuPont) Division
  • 94. DSM Hydrocolloids
  • 95. Duke University School of Medicine
  • 96. Duran Group
  • 97. Durata Therapeutics
  • 98. DWK Life Sciences
  • 99. Eastman Chemical
  • 100. Eisai
  • 101. Eli Lilly
  • 102. Elusys Therapeutics
  • 103. EMA Pharmaceuticals
  • 104. EMD Serono
  • 105. Enable Injections
  • 106. ExxonMobil Chemical
  • 107. EyePoint Pharmaceuticals
  • 108. FANUC America
  • 109. Fedegari Group
  • 110. Ferrer
  • 111. Fibrocell Technologies
  • 112. Fresenius Kabi
  • 113. GCL Pharma
  • 114. GE Healthcare Life Sciences
  • 115. Genentech
  • 116. German Institute of Rubber Technology (DIK)
  • 117. Gerresheimer
  • 118. Gilead Sciences
  • 119. GlaxoSmithKline
  • 120. Greenwich Biosciences
  • 121. H K Zion Industry
  • 122. HealthPrize Technologies
  • 123. Hebei First Rubber Medical Technology
  • 124. Helsinn Healthcare
  • 125. Henan Zhengzhou Songshan Enterprise Group
  • 126. Hubei Huaqiang High-Tech
  • 127. Hunan Runfuture Pharmatech
  • 128. Industria Macchine Automatiche (IMA)
  • 129. Infinity Pharmaceuticals
  • 130. Insmed
  • 131. Insulet
  • 132. Intercept Pharmaceuticals
  • 133. Ionis Pharmaceuticals
  • 134. IPM Technologies
  • 135. Ironwood Pharmaceuticals
  • 136. ITF Pharma
  • 137. Jain Rubbers
  • 138. Jamnadas Industries
  • 139. Janssen
  • 140. Jazz Pharmaceuticals
  • 141. Jiangsu Best New Medical Material
  • 142. Jiangsu Hualan New Pharmaceutical Material
  • 143. Jiangyin Aisun Import & Export
  • 144. Jiangyin Chengfeng Rubber and Plastic
  • 145. Jiangyin Hongmeng Rubber Plastic Product
  • 146. Jiangyin Tejie Rubber & Plastic
  • 147. Jiangyin Yonghong Rubber
  • 148. Jinan Youlyy Industrial
  • 149. JOTOP GLASS
  • 150. KAI Pharmaceuticals
  • 151. Kali Care
  • 152. Kawasaki Heavy Industries
  • 153. Kimble Chase
  • 154. Kite Pharma
  • 155. Kraton
  • 156. KUKA
  • 157. Kwality Pharma Rubber Industries
  • 158. KWK Kremsmünster
  • 159. Kyoraku
  • 160. KYTHERA Biopharmaceuticals
  • 161. La Jolla Pharmaceutical Company
  • 162. Lanxess
  • 163. Leadiant Biosciences
  • 164. Leibniz Association
  • 165. Lexicon Pharmaceuticals
  • 166. LifeSouth Community Blood Centers
  • 167. Lonstroff
  • 168. Loxo Oncology
  • 169. Lupin
  • 170. Malaysian Rubber Board
  • 171. Marchesini Group
  • 172. Massman Automation Designs
  • 173. Mayne Pharma
  • 174. Medicines Development for Global Health
  • 175. Megaplast
  • 176. Melinta Therapeutics
  • 177. Merck
  • 178. Millennium Pharmaceuticals
  • 179. Millipore Sigma
  • 180. Mitsubishi Tanabe Pharma
  • 181. MJS Packaging
  • 182. Momentive
  • 183. Motiba Silicone
  • 184. Mylan
  • 185. Naniwa Rubber
  • 186. National University of Ireland, Galway
  • 187. Neelam Global
  • 188. Neurocrine Biosciences
  • 189. Neutral Glass and Allied Industries
  • 190. New York Blood Center
  • 191. NextPharma Technologies
  • 192. Ningbo Xingya Rubber & Plastic
  • 193. Ningbo Zhengli Pharmaceutical Packing
  • 194. Nipro PharmaPackaging
  • 195. Noble International
  • 196. Nordson EFD
  • 197. Novartis
  • 198. Novimmune
  • 199. Novio
  • 200. Novo Nordisk
  • 201. NPS Pharmaceuticals
  • 202. Ocular Therapeutics
  • 203. Ohio State University
  • 204. Ompi (part of Stevanato Group)
  • 205. OMRON Industrial Automation
  • 206. Organogenesis
  • 207. Organon International
  • 208. Ortho Dermatologics
  • 209. Otsuka Pharmaceutical
  • 210. Ott
  • 211. Pack Source
  • 212. Paladin Labs
  • 213. Pall Biotech
  • 214. Pall Life Sciences
  • 215. Paratek Pharmaceuticals
  • 216. Pfizer
  • 217. PharMediPack Direkt
  • 218. Piramal Imaging
  • 219. Plas-Tech Engineering
  • 220. PolyOne
  • 221. Polytec Industries
  • 222. Portola Pharmaceuticals
  • 223. Prince Rubber & Plastics
  • 224. Prince Sterilization Services
  • 225. Propeller Health
  • 226. Prysmian Group
  • 227. PTC Therapeutics
  • 228. Puma Biotechnology
  • 229. Puyang Lumeng Glass Product
  • 230. PYRAMID Laboratories
  • 231. Qindao Huaren Medical
  • 232. Qure Medical
  • 233. Radius Health
  • 234. RAUMEDIC
  • 235. Regeneron Pharmaceuticals
  • 236. Relypsa
  • 237. Rempex Pharmaceuticals
  • 238. Retrophin
  • 239. Rigel Pharmaceuticals
  • 240. Rizhao Donggang Mtntai Industry and Trade
  • 241. Roche
  • 242. RubberMill
  • 243. Sagar Rubber Products
  • 244. Samsung Medical Rubber
  • 245. Sanofi
  • 246. Sanofi Genzyme
  • 247. Sarepta Therapeutics
  • 248. SCHOTT
  • 249. SCHOTT-KAISHA
  • 250. Seiko Epson
  • 251. Servier
  • 252. Shady Pack
  • 253. Shandong Pharmaceutical Glass
  • 254. Sheng Zou Rubber & Plastics
  • 255. Shenzhen Fushiyuan Rubber and Plastic Factory
  • 256. Shionogi
  • 257. Shire Pharmaceuticals
  • 258. Shreenidhi Rubber
  • 259. SHRIJI Rubber Industries
  • 260. Shrinath Products (a division of Elmer Products)
  • 261. Shyam Well Pack Industries
  • 262. SIGA Technologies
  • 263. SIGMA Plastic Services
  • 264. SKAN
  • 265. Sonata Rubber
  • 266. Spark Therapeutics
  • 267. Spectrum Pharmaceuticals
  • 268. Splendid Industry
  • 269. Sprout Pharmaceuticals
  • 270. SSM Health Cardinal Glennon Children's Hospital
  • 271. Staubli
  • 272. Stemline Therapeutics
  • 273. Steriline
  • 274. Stock Cap
  • 275. Strongbridge Biopharma
  • 276. Sumitomo Rubber Industries
  • 277. Sun Pharmaceutical Industries
  • 278. SureCare
  • 279. SVM Automatik
  • 280. Synergy Pharmaceuticals
  • 281. Taizhou Kanglong Pharmaceutical Packing
  • 282. Taiho Oncology
  • 283. TaiMed Biologics
  • 284. Taiwan Ta Sheh Heng Yi Enterprise Group
  • 285. Takeda Pharmaceuticals
  • 286. Tekpak
  • 287. TESARO
  • 288. Tetraphase Pharmaceuticals
  • 289. Teva Pharmaceutical Industries
  • 290. Teva Respiratory (part of Teva Pharmaceutical Industries)
  • 291. The Medicines Company
  • 292. The Plasticoid Company
  • 293. TherapeuticsMD
  • 294. Theravance Biopharma
  • 295. Tip-Top
  • 296. Tohoku University
  • 297. Triveni Polymers
  • 298. Tyndall National Institute
  • 299. UD Pharma Rubber Products
  • 300. Ultragenyx Pharmaceutical
  • 301. Union Chimique Belge
  • 302. United Scientific Supplies
  • 303. United Therapeutics
  • 304. Universal Medicap
  • 305. Universal Robots
  • 306. University of Colorado Cord Blood Bank
  • 307. Urologix
  • 308. US WorldMeds
  • 309. Valeant Pharmaceuticals
  • 310. Vanda Pharmaceuticals
  • 311. Vanrx Pharmasystems
  • 312. Verastem Oncology
  • 313. Vericel
  • 314. Vertex Pharmaceuticals
  • 315. Verux
  • 316. Vighnesh Rubbers
  • 317. Viscon Rubber
  • 318. VitaMed
  • 319. Vital Parts
  • 320. VWR (a part of Avantor)
  • 321. Weidmann Medical Technology
  • 322. Wellstat Therapeutics
  • 323. West Pharmaceutical Services
  • 324. Wheaton Industries
  • 325. Wyeth
  • 326. Xiamen Petrel Rubber & Plastic Products
  • 327. Yangjiang Jinbi Rubber Products
  • 328. Yangzhong Wealth Metal
  • 329. Yantai Xinhui Packing
  • 330. Yaskawa Electric
  • 331. Yichang Huaqiang Trade
  • 332. Zhengzhou Aoxiang Pharmaceutical Packing
  • 333. Zibo Dongda Medical Rubber
Back to Top